Heart Disease Clinical Trials in Miami

Showing 161-180 of 227 trials

Sapphire II PRO US Clinical Study

NCT03052530

A prospective, open label, multi-center, single arm, observational study designed to evaluate the acute safety and device procedural success of the Sapphire II PRO 1.0 and 1.25 mm PTCA dilatation catheters in subjects with stenotic coronary arteries or bypass grafts during percutaneous coronary intervention. Sixty (60) subjects will be treated at up to 5 U.S. sites with the Sapphire II PRO diameters 1.0 and 1.25 mm PTCA dilatation catheters to pre-dilate coronary arteries or bypass grafts during their index procedure. All subjects will be screened according to the protocol inclusion and exclusion criteria and will be followed through hospital discharge.

Coronary Artery DiseaseCoronary DiseaseMyocardial Ischemia+3 more

OrbusNeich61 participantsStarted May 2017

Miami, Florida, United States • Atlanta, Georgia, United States • Salisbury, Maryland, United States +1 more locations

TERMINATEDPhase 2/3< 1 mile

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

NCT00683696

The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic dysfunction, already receiving optimized HF medication, with a narrow QRS width (\< 130 ms) and echocardiographic evidence of ventricular dyssynchrony.

Heart FailureVentricular Dyssynchrony

Biotronik, Inc.1,680 participantsStarted Aug 2008

Concord, California, United States • Los Angeles, California, United States • Rancho Mirage, California, United States +119 more locations

Sapphire II PRO US Clinical Study

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Heart Disease Trials in Other Cities

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Niacin Plus Statin to Prevent Vascular Events

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

Naltrexone/Bupropion Cardiovascular Outcomes Study

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Natural History of Carotid Plaque as Determined by 3D Ultrasound

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

GORE Flow Reversal System and GORE Embolic Filter Extension Study

A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Evaluation of Vepoloxamer in Chronic Heart Failure

Sensor Optimization of Cardiac Resynchronization Therapy Response

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

The BOSS Study: An Acute Evaluation of Anatomical and Geometric Changes Using the Bladder on a Stick System (BOSS)

Other Conditions in Miami